![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Department of Public Health and Primary Health Care, Department of Pharmacology and LOCUS for Homocysteine and Related Vitamins, University of Bergen, N-5021 Bergen, Norway
2To whom correspondence should be addressed. E-mail: eha.nurk{at}isf.uib.no.
Plasma total homocysteine (tHcy) is a risk factor for cardiovascular disease, adverse pregnancy outcomes and impaired cognitive function. No population-based studies on the possible influence of prandial status on tHcy have been published. The aim of this study was to investigate the variation in plasma tHcy levels in relation to time since last meal. A cross-sectional, population-based study including 18,044 individuals in Western Norway was conducted. Most subjects were in the age groups 40–42 and 65–67 y. Participants who had not eaten during the past 6 h before the blood sampling had significantly higher mean tHcy levels compared with those who had eaten; 11.7 [95% confidence interval (CI): 11.4–12.1] vs. 11.2 (95% CI: 11.1–11.3) µmol/L among men (P = 0.03) and 10.2 (95% CI: 9.9–10.6) vs. 9.7 (95% CI: 9.6–9.7) µmol/L among women (P = 0.003). In all groups except older women, tHcy concentrations were generally higher with increasing time after a meal (P-trend <0.01 in all 3 groups). These findings suggest that fasting status and time since last meal may influence levels of tHcy and should be considered in studies of tHcy as a risk factor for cardiovascular and other diseases, and when comparing tHcy values among studies.
KEY WORDS: • homocysteine • prandial status • humans
This article has been cited by other articles:
|
|
 |
|
  L. Dodds, D. B. Fell, K. C. Dooley, B. A. Armson, A. C. Allen, B. A. Nassar, S. Perkins, and K.S. Joseph Effect of Homocysteine Concentration in Early Pregnancy on Gestational Hypertensive Disorders and Other Pregnancy Outcomes Clin. Chem., February 1, 2008; 54(2): 326 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Mignini, P. M. Latthe, J. Villar, M. D. Kilby, G. Carroli, and K. S. Khan Mapping the Theories of Preeclampsia: The Role of Homocysteine Obstet. Gynecol., February 1, 2005; 105(2): 411 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. McLean, P. F. Jacques, J. Selhub, K. L. Tucker, E. J. Samelson, K. E. Broe, M. T. Hannan, L. A. Cupples, and D. P. Kiel Homocysteine as a Predictive Factor for Hip Fracture in Older Persons N. Engl. J. Med., May 13, 2004; 350(20): 2042 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B Guttormsen, E. Solheim, and H. Refsum Variation in plasma cystathionine and its relation to changes in plasma concentrations of homocysteine and methionine in healthy subjects during a 24-h observation period Am. J. Clinical Nutrition, January 1, 2004; 79(1): 76 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al. Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion Clin. Chem., January 1, 2004; 50(1): 3 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-L. B. Monsen, H. Refsum, T. Markestad, and P. M. Ueland Cobalamin Status and Its Biochemical Markers Methylmalonic Acid and Homocysteine in Different Age Groups from 4 Days to 19 Years Clin. Chem., December 1, 2003; 49(12): 2067 - 2075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Fokkema, M. F. Gilissen, J. J. van Doormaal, M. Volmer, I. P. Kema, and F. A.J. Muskiet Fasting vs Nonfasting Plasma Homocysteine Concentrations for Diagnosis of Hyperhomocysteinemia Clin. Chem., May 1, 2003; 49(5): 818 - 821. [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Vasan, A. Beiser, R. B. D'Agostino, D. Levy, J. Selhub, P. F. Jacques, I. H. Rosenberg, and P. W. F. Wilson Plasma Homocysteine and Risk for Congestive Heart Failure in Adults Without Prior Myocardial Infarction JAMA, March 12, 2003; 289(10): 1251 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. Howard, E. G. Sides, G. C. Newman, S. N. Cohen, G. Howard, M. R. Malinow, and J. F. Toole Changes in Plasma Homocyst(e)ine in the Acute Phase After Stroke Stroke, February 1, 2002; 33(2): 473 - 478. [Abstract] [Full Text] [PDF]
|
|
